U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199517) titled 'PUQS Sampling Study' on Sept. 22.
Brief Summary: This study aims to investigate harm-reduction sampling in a choice format versus medicinal nicotine sampling on smoking behavior, identify mechanisms of sampling's effects, and explore moderators of these effects among a national sample of people unmotivated to quit smoking. Participants will be randomized 2:1 to choose one of three harm-reduction products (ECIG, IQOS, ONP) versus a medicinal nicotine control condition (nicotine patch + lozenge, NPL), receive a 4-week starter product regimen, and then be followed for 6 months to assess use behavior.
Study Start Date: Dec., 2025
Study...